Federal Epinephrine Access & Legislative Grant Resources

Federal law that gives states preference for Preventive Health and Health Services Block Grant funding if they require or allow schools to maintain a supply of undesignated (stock) epinephrine and permit trained personnel to administer it.

Asthma and Allergy Foundation of America summary of the federal law and how it interacts with state stock-epinephrine legislation for schools and childcare.

Federal guidance document from the CDC covering emergency preparedness, including maintaining stock epinephrine auto-injectors, for K-12 schools and early care/childcare settings.

The CDC’s only federal program dedicated to asthma; funds state health departments to improve school and community-based asthma management, including emergency medication access policy.

Food Allergy Research & Education directory tracking which states permit or require entities — including schools and childcare — to stock undesignated epinephrine, and the responsible state agency.

Peer-reviewed national review confirming all 50 states + DC allow undesignated epinephrine in schools; 14 mandate it and 37 permit it. The authoritative federal-level review of the mandate landscape this law was designed to encourage.

The primary federal funding source for child care subsidies to low-income working families. States receiving CCDF funds must set health and safety standards for providers, including medication administration training — the federal lever that drives childcare allergy and emergency-medication policy nationwide.

Federal regulation requiring all CCDF-funded child care providers to complete training in medication administration, including emergency medications such as epinephrine auto-injectors. The regulatory backbone for childcare stock-epinephrine preparedness.

Official Administration for Children and Families presentation walking through the health and safety training requirements under CCDF reauthorization, including administration of medication and emergency preparedness in child care settings.

Federal program funding comprehensive early childhood development services for low-income children from birth to age 5. Head Start programs must meet health and safety performance standards covering medication administration and emergency response, including epinephrine.

HRSA grants funding maternal and child health programs — including the EMS for Children program and state MCH block grants — that support pediatric emergency preparedness, anaphylaxis response training, and child care health consultation.

Congressional Research Service report explaining how CCDBG funding flows to states, the health and safety requirements attached to it, and how advocates can engage the reauthorization process to strengthen childcare allergy and emergency-medication policy.

The official U.S. government-wide portal to search and apply for every federal grant opportunity, including CDC, HRSA, and NIH programs relevant to asthma and allergy legislation, education, and emergency-response funding.

Recurring CDC notice of funding opportunity (NOFO) for state and local health departments to improve guidelines-based asthma care, school policy, and chronic-disease legislative support.

CDC-administered block grant to all 50 states, DC, and 8 territories that gives funding preference to states adopting the stock-epinephrine school policies encouraged by the School Access to Emergency Epinephrine Act.

Health Resources and Services Administration hub for maternal & child health, rural health, and community health grant opportunities that can support school-based emergency medication and asthma/allergy programs.

National Institute of Allergy and Infectious Diseases program funding multi-center translational research centers studying asthma and allergic disease — a pipeline for the clinical evidence that informs legislation.

AAFA’s guide to the federal agencies, programs, and appropriations advocates can lobby Congress to fund or protect for asthma and allergy legislation, research, and school health policy.